Cell-Based Assays for G-Protein-Coupled/Tyrosine Kinase-Coupled Receptors

Abstract

Using mammalian cells transiently transfected with receptors, we have developed an assay [Receptor Selection and Amplification Technology (R-SAT); patents pending] that links ligand-dependent cellular transformation to induction of 8-galactosidase in a 96-well plate format. Using these procedures, we have performed high throughput functional assays of receptors that mediate signal transduction by a diversity of mechanisms. Examples include the prostanoid, muscarinic, and neurokinin receptor subtypes that signal via the G-proteins Gq and Gi, the JAK/STAT-linked GM-CSF receptor, the tyrosine kinase neurotrophin receptors, and the classical oncogenes v-ras and p53. The assays have been formatted such that many receptors can be assayed simultaneously (>10 receptors per well) and precise discrimination of ligand efficacy can be obtained (e.g., full and partial agonists, negative and neutral antagonists).

References

Brann, M.R. (ed.) (1991). Molecular Biology of G-Protein Coupled Receptors. Birkhauser, Boston.

Genbank. World wide web. http://www.ncbi.nlm.nih.gov/ (1995).

Julius, D. , Livelli, Y.J. , Jessell, T.M. , Axel, R. (1989). Ectopic expression of the serotonin Ic receptor and the triggering of malignant transformation. Science 244:1057.

Gutkind, J.S. , Novotny, E.A. , Brann, M.R. , Robbins, K.C. (1991). Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc. Nadl. Acad. Sci. U.S.A. 88:4703.

Allen, L.F. , Lefkowitz, R.J. , Caron, M.G. , Cotecchia, S. (1991). G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the alpha-IB-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 88:11354.

Jainchill, J.L. , Aaronson, S.A. , Todaro, G.J. (1969). Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549.

Lim, K. , Chae, C.-B. (1989). A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. BioTechniques 7:576.

Messier, T.L. , Dorman, C.M. , Brauner-Osbome, H. , Brann, M.R. (1995). High throughput assays of cloned adrenergic, muscarinic, neurokinin, and neurotrophin receptors in living mammalian cells. Pharmacol. Toxicol. 76:308.

Brauner-Osborne, H. , Brann, M.R. (1996). Pharmacology of muscarinic acetylcholine receptor subtypes (mI-m5): High throughput assays in mammalian cells. Eur. J. Pharm. 295:78-102.

10.

Tecle, H. , Lauffer, D.J. , Davis, R.E. , Mirzadegan, T. , Moreland, D.W. , Schwarz, R.D. , Thomas, A.J. , Raby, C. , Eubanks, D. , Brann, M.R. , Jaen, J.C. (1995). (+)-l-Azabicyclo(2.2.1)heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists. Bioorg. Med. Chem. Lett. 5:637.

11.

Brauner-Osborne, H. , Ebert, B. , Brann, M.R. , Falch, E. , and Krogsgaard-Larsen, P. (1995). Annulated heterocyclic bioesosteres of norarecoline: synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors. J. Med. Chem. 38:2188.

12.

Gil, D.I. , Messier, T. , Eubanks, D. , Brann, M.R. (1995). Cotransfection of a2-C1O adrenergic receptor with G-protein alpha subunits dramatically increases agonist potency in PI and R-SAT assays. Soc. Neurosci. Abstr. 21(2):1611.

13.

Burstein, E.S. , Spalding, T.A. , Brauner-Osborne, H. , Brann, M.R. (1995). Constitutive activation of muscarinic receptors by the G-protein Gq. FEBS Lett. 363:261.

14.

Burstein, E.S. , Spalding, T.A. , Hill-Eubanks, D. , Brann, M.R. (1995). Structure/function of muscarinic receptor coupling to G proteins. J. Biol. Chem. 270:3141.

15.

Spalding, T.A. , Burstein, E. , Brauner-Osbome, H. , Hill-Eubanks, D. , Brann, M.R. (1995). Constitutively active muscarinic receptors generated by random mutagenesis. J. Pharm. Exp. Ther. 275:1274.